Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03049618
Title Recombinant EphB4-HSA Fusion Protein and Pembrolizumab, MK-3475
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Southern California
Indications

lung non-small cell carcinoma

head and neck squamous cell carcinoma

Therapies

Pembrolizumab + sEphB4-HSA

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
USC / Norris Comprehensive Cancer Center Los Angeles California 90033 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field